AzTrials
AzTrials

Refractive AssessmentNCT07046065

Algorithm-assisted Subjective Refraction Program Dedicated to Children

A study testing Non-cycloplegic Objective refraction, Non-cycloplegic conventional subjective refraction and Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-R™) in people with Refractive Assessment and Refractive Disorders, run by Essilor International at 1 site in Portugal.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Current refraction assessment in children is dependent on the Eye Care Specialist and lacks standardization. Essilor has developed new algorithm assisted subjective refraction software dedicated to children of 6-12 years old and suitable for use with Vision-S™ and Vision-R™ phoropters, in addition to existing… Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
What is being tested?
Non-cycloplegic Objective refraction, Non-cycloplegic conventional subjective refraction and Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-R™)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
166 participants
Where
1 sitePortugal
Study dates
23 May 2025to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age between 6 and 12 years
  • Subject able to recognize and name the letters of the Latin alphabet
  • Pupillary distance (PD) not less than 49mm
  • Distance refractive error for spherical equivalence (SE) within the range of [-6.00 to +6.00 D] maximum of the two absolute values RE and LE; Cyl ≤ 3.00 D
  • Monocular Visual acuity ≥ +0.30 LogMAR (0.5 Decimal VA) in each eye at distance
  • Visual acuity difference < 0.20 logMAR between right and left eyes at distance

Who cannot join

  • Vulnerability of the subject
  • Amblyopia
  • Strabismus
  • Any current or evolving pathology manifested in the eye or the appendages which might have an influence on vision, or interfere with refractive state
  • Any previous ocular surgery, which might have an influence on vision or interfere with study assessments (e.g. iridectomy, refractive surgery…)
  • Any ocular or systemic condition known to affect refractive status (e.g., keratoconus, diabetes, Down's syndrome, etc.)
Show all 13Show fewer
  • Any neurological or speech disorders that might interfere with the ability to understand and answer questions or communicate with the ECP
  • Any untreated and/or uncontrolled systemic condition which might have an influence on vision or interfere with study assessments
  • Current use of ocular or systemic medications, which, in the Investigator's opinion, may significantly affect pupil size, accommodation or refractive state
  • History of myopia control intervention that may affect refractive assessment (e.g., atropine, orthokeratology, rigid gas permeable lenses (RGP) etc.) except myopia control spectacles
  • Contraindications of cycloplegia (e.g. high Intra-ocular pressure - more than 22mmHg in either eye, narrow anterior angle, history of allergy to cycloplegic agents or seizures, etc)
  • Aphakic or pseudoaphakic (intraocular lens),
  • Prismatic prescription in either Right or Left eye (horizontal or vertical). -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ana Júlia Sousa contact

+351 21 409 60 79

asousa@evidenze.com

Portugal1 site, 1 recruiting
  • Centro de Investigação, Inovação e Ensino Superior (CIIES) de Famalicão

    Vila Nova de Famalicão, 4764-502

    José Manuel González- Meijome, PhD, jgmeijome@fisica.uminho.pt

    Botelho Fernandes, pfernandes@fisica.uminho.pt

    Recruiting

Other trials in Portugal

About this study

Current refraction assessment in children is dependent on the Eye Care Specialist and lacks standardization. Essilor has developed new algorithm assisted subjective refraction software dedicated to children of 6-12 years old and suitable for use with Vision-S™ and Vision-R™ phoropters, in addition to existing software.

Two different versions of the software have been developed: the first incorporating only the steps needed to perform an entire subjective refraction process (vA), and the second, identical to the first but incorporating additional steps useful for managing the child's attention and cooperation (vB).

The software performance in terms of subjective refraction results will be compared to a conventional subjective refraction method performed with the Vision-R™700 phoropter in manual mode.

Read the detailed description

The goal of the investigation is to evaluate the accuracy of the Kids refraction software results performed with the phoropters Vision-R™700 and Vision-S™700 compared to the conventional subjective refraction method results performed with Vision-R™700. Phase A of the investigation will focus on the validation of the first version (Kids refraction software vA), and phase B will involve the second version (Kids refraction software vB).

There are two phases in the investigation:

Phase A:

To evaluate the agreement of the subjective refraction results (Sphere, Cylinder, Axis, VA) between the Kids Refraction software vA (randomization between Vision-R or Vision-S devices) results and a conventional subjective refraction (performed with Vision-R), in a non-cycloplegic condition.

Phase B:

To evaluate the agreement of the subjective refraction results (Sphere, Cylinder, Axis, VA) between the Kids Refraction software vB with additional attention and cooperation stages (randomization between Vision-R or Vision-S devices) results and a conventional subjective refraction (performed with Vision-R), in a non-cycloplegic condition.

Being tested
Non-cycloplegic Objective refraction, Non-cycloplegic conventional subjective refraction, Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-R™), Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-S™), Non-cycloplegic subjective refraction (Kids refraction software vB with Vision-R™)
Keywords
cycloplegic refraction, non-cycloplegic refraction, subjective refraction
Medical subject headings
Refractive Errors, Hyperopia, Myopia, Astigmatism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-cycloplegic Objective refractionDevice

    Objective refraction will be measured using an auto-kerato-refractometer/aberrometer without cyclopegia

  • Non-cycloplegic conventional subjective refractionDevice

    Performed with Vision-R™

  • Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-R™)Device

    Performed with Vision-R™

  • Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-S™)Device

    Performed with Vision-S™

  • Non-cycloplegic subjective refraction (Kids refraction software vB with Vision-R™)Device

    Performed with Vision-R™

  • Non-cycloplegic subjective refraction (Kids refraction software vB with Vision-S™)Device

    Performed with Vision-S™

  • Cycloplegic subjective refraction (Kids refraction software vA with Vision-R™)Device

    Performed with Vision-R™

  • Cycloplegic subjective refraction (Kids refraction software vA with Vision-S™)Device

    Performed with Vision-S™

  • Cycloplegic Objective refractionDevice

    Objective refraction will be measured using an auto-kerato-refractometer/aberrometer with cyclopegia

  • Non-cycloplegic RetinoscopyDevice

    Performed with a retinoscope without cycloplegia

  • Cycloplegic retinoscopyDevice

    Performed with a retinoscope with cycloplegia

Study groups in NCT07046065
Study groupRoleWhat they receive
Validation of the Kids Refraction softwares vA and vB performed with Vision-R™ phoropterActive comparatorMeasurement of the non-cycloplegic refraction with Vision-R™ phoropter and comparison with the conventional refraction measurement method. Measurement of the cycloplegic refraction with Vision-R™ phoropter and comparison with non-cycloplegic refraction with Vision-R™ phoropter.
Receives: Device: Non-cycloplegic Objective refraction; Device: Non-cycloplegic conventional subjective refraction; Device: Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-R™); Device: Non-cycloplegic subjective refraction (Kids refraction software vB with Vision-R™); Device: Cycloplegic subjective refraction (Kids refraction software vA with Vision-R™); Device: Cycloplegic Objective refraction; Device: Non-cycloplegic Retinoscopy; Device: Cycloplegic retinoscopy
Validation of the Kids Refraction softwares vA and vB performed with Vision-S™ phoropterActive comparatorMeasurement of the non-cycloplegic refraction with Vision-S™ phoropter and comparison with the conventional refraction measurement method. Measurement of the cycloplegic refraction with Vision-S™ phoropter and comparison with non-cycloplegic refraction with Vision-S™ phoropter.
Receives: Device: Non-cycloplegic Objective refraction; Device: Non-cycloplegic conventional subjective refraction; Device: Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-S™); Device: Non-cycloplegic subjective refraction (Kids refraction software vB with Vision-S™); Device: Cycloplegic subjective refraction (Kids refraction software vA with Vision-S™); Device: Cycloplegic Objective refraction; Device: Non-cycloplegic Retinoscopy; Device: Cycloplegic retinoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective Sphere (with Kids refraction software vA, with Vision-R™ and with Vision-S™)

    The term "sphere" means that the correction for myopia or hyperopia is spherical, equal in all meridians of the eye. This indicates the amount of lens power, measured in diopters (D), prescribed to correct myopia or hyperopia.

    Measured: Day 1

  2. Subjective Cylinder (with Kids refraction software vA, with Vision-R™ and with Vision-S™)

    Indicates the amount of lens power for astigmatism, measured in diopters (D) and represents the difference in the greatest and weakest powers of the eye, usually separated by 90 degrees.

    Measured: Day 1

  3. Subjective Axis (with Kids refraction software vA, with Vision-R™ and with Vision-S™)

    Indicates the orientation of the Cylinder, measured in degrees (°)

    Measured: Day 1

  4. Subjective Sphere (with Kids refraction software vB, with Vision-R™ and with Vision-S™)

    The term "sphere" means that the correction for myopia or hyperopia is spherical, equal in all meridians of the eye. This indicates the amount of lens power, measured in diopters (D), prescribed to correct myopia or hyperopia.

    Measured: Six months after Day 1

  5. Subjective Cylinder (with Kids refraction software vB, with Vision-R™ and with Vision-S™)

    Indicates the amount of lens power for astigmatism, measured in diopters (D) and represents the difference in the greatest and weakest powers of the eye, usually separated by 90 degrees.

    Measured: Six months after Day 1

  6. Subjective Axis (with Kids refraction software vB, with Vision-R™ and with Vision-S™)

    Indicates the orientation of the Cylinder, measured in degrees (°)

    Measured: Six months after Day 1

  7. Subjective Sphere (with conventional method with Vision-R™)

    The term "sphere" means that the correction for myopia or hyperopia is spherical, equal in all meridians of the eye. This indicates the amount of lens power, measured in diopters (D), prescribed to correct myopia or hyperopia.

    Measured: Day 1

  8. Subjective Cylinder (with conventional method, with Vision-R™)

    Indicates the amount of lens power for astigmatism, measured in diopters (D) and represents the difference in the greatest and weakest powers of the eye, usually separated by 90 degrees.

    Measured: Day 1

  9. Subjective Axis (with conventional method, with Vision-R™)

    Indicates the orientation of the Cylinder, measured in degrees (°)

    Measured: Day 1

  10. Visual acuity (with Kids refraction software vA, with Vision-R™ and with Vision-S™)

    Corrected visual acuity measure with Kids refraction software vA results

    Measured: From enrollment (Day 1) to the end of the study at 7,5 months

  11. Visual acuity (with Kids refraction software vB, with Vision-R™ and with Vision-S™)

    Corrected visual acuity measure with Kids refraction software vB results

    Measured: From enrollment (Day 1) to the end of the study at 7,5 months

  12. Visual acuity (with Conventionnal refraction method, with Vision-R™)

    Corrected visual acuity measure with Conventionnal refraction method results

    Measured: From enrollment (Day 1) to the end of the study at 7,5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2025
  2. Study start23 May 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
166 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07046065
Sponsor's protocol ID
WS10374
Other IDs
CIV-25-03-051757
Status last verified
Jun 2025
First submitted
12 Jun 2025
Last updated
1 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no need to share individual anonymized data.

Questions about this trial

What is this clinical trial studying?

A study testing Non-cycloplegic Objective refraction, Non-cycloplegic conventional subjective refraction and Non-cycloplegic subjective refraction (Kids refraction software vA with Vision-R™) in people with Refractive Assessment and Refractive Disorders, run by Essilor International at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ana Júlia Sousa (+351 21 409 60 79, asousa@evidenze.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective Sphere (with Kids refraction software vA, with Vision-R™ and with Vision-S™) (time frame: Day 1). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in